摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

4-碘-3-甲基吡啶 | 22282-64-0

中文名称
4-碘-3-甲基吡啶
中文别名
——
英文名称
4-Jod-3-methyl-pyridin
英文别名
4-iodo-3-methyl-pyridine;4-Iodo-3-methylpyridine
4-碘-3-甲基吡啶化学式
CAS
22282-64-0
化学式
C6H6IN
mdl
——
分子量
219.025
InChiKey
NSTUUHPBPDFGMR-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 熔点:
    46-48 °C
  • 沸点:
    237.4±20.0 °C(Predicted)
  • 密度:
    1.810±0.06 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    1.9
  • 重原子数:
    8
  • 可旋转键数:
    0
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    0.17
  • 拓扑面积:
    12.9
  • 氢给体数:
    0
  • 氢受体数:
    1

安全信息

  • 海关编码:
    2933399090

文献信息

  • CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME
    申请人:Samsung Electronics Co., Ltd.
    公开号:US20210198222A1
    公开(公告)日:2021-07-01
    Provided are a condensed cyclic compound represented by Formula 1 and an organic light-emitting device including the same: wherein, in Formula 1, X 1 , A 1 , L 11 , a11, Ar 11 , Ar 12 , b11, R 11 , R 12 , c11, and c12 are the same as defined in the specification.
    提供了由化学式1表示的简化环化合物和包括该化合物的有机发光器件:在化学式1中,X1、A1、L11、a11、Ar11、Ar12、b11、R11、R12、c11和c12的定义与规范中定义的相同。
  • CONDENSED-CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING THE SAME
    申请人:Samsung Display Co., Ltd.
    公开号:US20190071458A1
    公开(公告)日:2019-03-07
    A condensed-cyclic compound and an organic light-emitting device including the same are provided. The compound is represented by the formula wherein ring A, ring B, and ring C are each independently selected from a C 5 -C 30 carbocyclic group and a C 1 -C 30 heterocyclic group, each of L 1 to L 9 is independently selected from a substituted or unsubstituted C 3 -C 10 cycloalkylene group, a substituted or unsubstituted C 1 -C 10 heterocycloalkylene group, a substituted or unsubstituted C 3 -C 10 cycloalkenylene group, a substituted or unsubstituted C 1 -C 10 heterocycloalkenylene group, a substituted or unsubstituted C 6 -C 60 arylene group, a substituted or unsubstituted C 1 -C 60 heteroarylene group, a substituted or unsubstituted divalent non-aromatic condensed polycyclic group, and a substituted or unsubstituted divalent non-aromatic condensed heteropolycyclic group, and each of Ar 1 to Ar 6 , R1 to R3, R 11 , and R 12 are further defined. The compound may be incorporated into one or more layers of an organic light-emitting diode device.
    提供了一种浓缩环状化合物和包括该化合物的有机发光器件。该化合物由下式表示,其中环A、环B和环C分别独立地选自C5-C30碳环族和C1-C30杂环族,L1至L9中的每一个独立地选自取代或未取代的C3-C10环烷基组、取代或未取代的C1-C10杂环烷基组、取代或未取代的C3-C10环烯基组、取代或未取代的C1-C10杂环烯基组、取代或未取代的C6-C60芳基组、取代或未取代的C1-C60杂芳基组、取代或未取代的双价非芳香缩合多环族和取代或未取代的双价非芳香缩合杂多环族,Ar1至Ar6、R1至R3、R11和R12进一步定义。该化合物可以被用于有机发光二极管器件的一个或多个层中。
  • ORGANOMETALLIC COMPOUND, ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME AND DIAGNOSTIC COMPOSITION INCLUDING THE ORGANOMETALLIC COMPOUND
    申请人:Samsung Electronics Co., Ltd.
    公开号:US20210198297A1
    公开(公告)日:2021-07-01
    Provided are an organometallic compound, an organic light-emitting device including the same, and a diagnostic composition including the same. The organometallic compound is represented by Formula 1 M(L A ) n1 (L B ) n2 wherein, in Formula 1, M is a transition metal, L A is a ligand represented by Formula 2A, L B is a ligand represented by Formula 2B,
    提供了一个有机金属化合物,包括该化合物的有机发光器件,以及包括该化合物的诊断组合物。该有机金属化合物由Formula 1M(LA)n1(LB)n2表示,在Formula 1中,M是过渡金属,LA是由Formula 2A表示的配体,LB是由Formula 2B表示的配体。
  • ORGANOMETALLIC COMPOUND, ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE ORGANOMETALLIC COMPOUND, AND DIAGNOSTIC COMPOSITION INCLUDING THE ORGANOMETALLIC COMPOUND
    申请人:Samsung Electronics Co., Ltd.
    公开号:US20200181184A1
    公开(公告)日:2020-06-11
    An organometallic compound represented by Formula 1: M(L 1 ) n1 (L 2 ) n2 Formula 1 wherein, in Formula 1, M is a transition metal, L 1 is a ligand represented by Formula 2A, L 2 is a ligand represented by Formula 2B, n1 is 1 or 2, wherein, when n1 is 2, two groups L 1 are identical to or different from each other, n2 is 1 or 2, wherein, when n2 is 2, two group L 2 are identical to or different from each other, the sum of n1 and n2 is 2 or 3, and L 1 and L 2 are different from each other wherein X 1 , ring CY 1 , ring CY 2 , ring CY 14 , R 1 to R 3 , R 11 to R 14 , Z 1 to Z 3 , a1, a2, a3, b1, and c1 are the same as described in the description, and * and *′ in Formulae 2A and 2B each indicate a binding site to M in Formula 1.
    一种由化学式1表示的有机金属化合物:M(L1)n1(L2)n2 化学式1中,在化学式1中,M是过渡金属,L1是由化学式2A表示的配体,L2是由化学式2B表示的配体,n1为1或2,当n1为2时,两个基团L1可以相同也可以不同,n2为1或2,当n2为2时,两个基团L2可以相同也可以不同,n1和n2的总和为2或3,且L1和L2不同 其中X1、环CY1、环CY2、环CY14、R1到R3、R11到R14、Z1到Z3、a1、a2、a3、b1和c1与描述中的相同,化学式2A和2B中的*和*′分别表示化学式1中与M结合的结合位点。
  • [EN] SUBSTITUTED IMIDAZO[1,5-a]QUINOXALINES AS INHIBITORS OF PHOSPHODIESTERASE 10<br/>[FR] IMIDAZO[1,5-A]QUINOXALINES SUBSTITUÉES EN TANT QU'INHIBITEURS DE LA PHOSPHODIESTÉRASE 10
    申请人:WYETH CORP
    公开号:WO2010138833A1
    公开(公告)日:2010-12-02
    The invention relates to imidazo[1,5-a]quinoxaline derivatives which are inhibitors of phosphodiesterase 10 (PDE10) useful in treating central nervous system diseases such as psychosis and also in treating, for example, obesity, type 2 diabetes, metabolic syndrome, glucose intolerance, and pain.
    该发明涉及imidazo[1,5-a]quinoxaline衍生物,它们是磷酸二酯酶10(PDE10)的抑制剂,可用于治疗中枢神经系统疾病,如精神病,也可用于治疗肥胖症、2型糖尿病、代谢综合征、葡萄糖不耐受和疼痛等疾病。
查看更多

同类化合物

(S)-氨氯地平-d4 (R,S)-可替宁N-氧化物-甲基-d3 (R)-N'-亚硝基尼古丁 (5E)-5-[(2,5-二甲基-1-吡啶-3-基-吡咯-3-基)亚甲基]-2-亚磺酰基-1,3-噻唑烷-4-酮 (5-溴-3-吡啶基)[4-(1-吡咯烷基)-1-哌啶基]甲酮 (5-氨基-6-氰基-7-甲基[1,2]噻唑并[4,5-b]吡啶-3-甲酰胺) (2S)-2-[[[9-丙-2-基-6-[(4-吡啶-2-基苯基)甲基氨基]嘌呤-2-基]氨基]丁-1-醇 (2R,2''R)-(+)-[N,N''-双(2-吡啶基甲基)]-2,2''-联吡咯烷四盐酸盐 黄色素-37 麦斯明-D4 麦司明 麝香吡啶 鲁非罗尼 鲁卡他胺 高氯酸N-甲基甲基吡啶正离子 高氯酸,吡啶 高奎宁酸 马来酸溴苯那敏 马来酸左氨氯地平 顺式-双(异硫氰基)(2,2'-联吡啶基-4,4'-二羧基)(4,4'-二-壬基-2'-联吡啶基)钌(II) 顺式-二氯二(4-氯吡啶)铂 顺式-二(2,2'-联吡啶)二氯铬氯化物 顺式-1-(4-甲氧基苄基)-3-羟基-5-(3-吡啶)-2-吡咯烷酮 顺-双(2,2-二吡啶)二氯化钌(II) 水合物 顺-双(2,2'-二吡啶基)二氯化钌(II)二水合物 顺-二氯二(吡啶)铂(II) 顺-二(2,2'-联吡啶)二氯化钌(II)二水合物 非那吡啶 非洛地平杂质C 非洛地平 非戈替尼 非尼拉朵 非尼拉敏 阿雷地平 阿瑞洛莫 阿培利司N-6 阿伐曲波帕杂质40 间硝苯地平 间-硝苯地平 锇二(2,2'-联吡啶)氯化物 链黑霉素 链黑菌素 银杏酮盐酸盐 铬二烟酸盐 铝三烟酸盐 铜-缩氨基硫脲络合物 铜(2+)乙酸酯吡啶(1:2:1) 铁5-甲氧基-6-甲基-1-氧代-2-吡啶酮 钾4-氨基-3,6-二氯-2-吡啶羧酸酯 钯,二氯双(3-氯吡啶-κN)-,(SP-4-1)-